Section of Perinatology, Philippine Children's Medical Center, Quezon City, Philippines.
Int J Gynaecol Obstet. 2024 May;165(2):474-479. doi: 10.1002/ijgo.15348. Epub 2024 Jan 8.
The main objective of the study was to determine if ultrasonographic measurement of mediastinal shift angle (MSA) can predict postnatal survival in fetuses with isolated left congenital diaphragmatic hernia (CDH). This relatively new technique may be used to enhance antenatal prediction of survival in fetuses with CDH.
A retrospective cross-sectional study was conducted at the Philippine Children's Medical Center involving 16 cases with prenatally diagnosed isolated left CDH and 60 controls with normal fetuses. The cases with prenatally diagnosed isolated left CDH were allocated into two groups: Group A (survivors) and group B (non-survivors). For all fetuses (study and control groups), MSA was determined independently by two operators. The diagnostic capacity of MSA was assessed using the receiver operating characteristic curve.
The mean MSA for the control group was 17.18°. Among CDH cases, the mean MSA was 33.04° and 37.57° for survivors and non-survivors, respectively. Results showed that MSA significantly predicted the probability of neonatal survival status (OR = 0.46, P = 0.021). The best cutoff score of MSA based on the receiver operating characteristic curve was 33.80° with 87.50% sensitivity and specificity.
MSA has the potential to enhance antenatal prediction of survival in fetuses with CDH and may serve as a guide in prenatal counseling and evaluation of the need for in-utero treatment or postnatal procedures.
本研究的主要目的是确定纵隔移位角(MSA)的超声测量是否可以预测孤立性左侧先天性膈疝(CDH)胎儿的产后生存情况。这项相对较新的技术可用于增强对 CDH 胎儿存活的产前预测。
菲律宾儿童医疗中心进行了一项回顾性病例对照研究,共纳入 16 例产前诊断为孤立性左侧 CDH 的病例和 60 例正常胎儿的对照组。将产前诊断为孤立性左侧 CDH 的病例分为两组:A 组(存活组)和 B 组(死亡组)。对所有胎儿(研究组和对照组),由两名操作人员独立测量 MSA。使用受试者工作特征曲线评估 MSA 的诊断能力。
对照组的平均 MSA 为 17.18°。在 CDH 病例中,存活者的平均 MSA 为 33.04°,死亡者为 37.57°。结果表明,MSA 显著预测新生儿生存状态的概率(OR=0.46,P=0.021)。基于受试者工作特征曲线的最佳 MSA 截断值为 33.80°,其敏感性和特异性分别为 87.50%和 87.50%。
MSA 有可能增强对 CDH 胎儿存活的产前预测,并可作为产前咨询和评估宫内治疗或产后治疗必要性的指导。